Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SHC adaptor protein 2 (SHC2) is an intracellular adaptor protein, a member of the Shc family, that plays a critical role in coupling activated growth factor receptors—especially receptor tyrosine kinases and notably in neuronal cells—to downstream signal transduction pathways. SHC2 contains distinct Src homology 2 (SH2) and phosphotyrosine-binding (PTB) domains, enabling its interaction with phosphorylated tyrosine residues on activated receptors like neurotrophin Trk receptors and EGFR. Lacking intrinsic enzymatic activity, SHC2 functions as a critical scaffold for assembling signaling complexes, linking extracellular stimuli to cellular processes such as proliferation, differentiation, survival, and migration. Deregulation of SHC2 is implicated in diseases including cancer and neurodegeneration. Although SHC2 is a key intracellular adaptor involved in neuronal signal transduction and disease association, it is not typically considered a direct drug target or biomarker.
no direct mechanism, as SHC2 is mostly targeted through modulation of associated pathways such as receptor tyrosine kinase inhibitors or downstream effectors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SHC adaptor protein 2 (SHC2).